Somerville, NJ, May 17, 2018 --(PR.com
)-- World-renowned goalkeeper Tim Howard reaffirms his commitment to improving the lives of individuals with Tourette Syndrome by continuing his appointment as a member of the Board of Directors for the NJ Center for Tourette Syndrome and Associated Disorders (NJCTS). Howard has been associated with NJCTS, the nation’s first Center of Excellence for Tourette Syndrome, since its founding.
Over the years, the North Brunswick, NJ, native has shared his personal experience with Tourette Syndrome (TS)—a misunderstood and misdiagnosed neurological disorder that affects 1 in 100 individuals, characterized by vocal sounds and motor movements called tics. He was diagnosed in middle school.
“Tim Howard’s partnership with NJCTS was formed when he publicly announced his TS diagnosis in 2000,” said NJCTS Executive Director Faith W. Rice. “We are delighted to have Tim’s continued support and inspiration as we work toward making lives better for individuals and families living with Tourette Syndrome.”
Howard has had a stellar career, making his Major League Soccer debut in 1998 with the New York/New Jersey MetroStars. He spent 13 years overseas playing for the English Premier League’s Manchester United and Everton Football Clubs, while representing the US Men’s National Team every year since 2002. He has served in goal for the Colorado Rapids since 2016. As his star rose, he worked with NJCTS to bring Tourette Syndrome awareness to the global stage.
In addition to serving as an NJCTS board member, Howard is also a critical partner in NJCTS’s anti-stigma, Tourette Syndrome awareness platform, The GreaTS and helped bring to fruition the NJCTS Tim Howard Leadership Academy, now in its fifth year.
The NJ Center for Tourette Syndrome and Associated Disorders, the nation’s first Center for Excellence for Tourette Syndrome, is a not-for-profit organization committed to the advocacy of children and families with Tourette Syndrome and its associated disorders. Dedicated to delivering high quality services to these individuals, the Center recognizes the importance of educating the public, medical professionals, and teachers about this disorder through programs and affiliations with public schools, health centers, and universities. Visit www.njcts.org for more information.